8 result(s)
-
1.
Amgen Research (Munich) GmbH (Re) - 2021 CACP 2 - 2021-01-06
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
2.
Rijk Zwaan Zaadteelt en Zaahandel B.V. (Re) - 2021 CACP 5 - 2021-01-29
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Disclosure - Adequacy or Deficiency of Description
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm)
-
3.
Genentech, Inc. (Re) - 2021 CACP 8 - 2021-03-17
PatentsSubject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
4.
Nektar Therapeutics (Re) - 2021 CACP 13 - 2021-03-25
PatentsSubject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
5.
Alexion Pharmaceuticals, Inc. (Re) - 2021 CACP 41 - 2021-09-09
PatentsSubject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
6.
Biogen MA Inc. (Re) - 2022 CACP 2 - 2022-01-24
PatentsClaims - Excessive Width - Not Supported by Disclosure
Disclosure - Adequacy or Deficiency of Description
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
-
7.
Merz Pharma GMBH & Co. KGAA (Re) - 2022 CACP 3 - 2022-01-27
PatentsClaims - Ambiguity or Indefiniteness (incomplete)
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of
Utility - Utility
-
8.
Ipsen Pharma S.A.S. (Re) - 2022 CACP 11 - 2022-04-01
PatentsDivision - Division
Novelty - Novelty
Obviousness - Obviousness
Subject Matter (part 1) - Professional or Artistic Skill
Subject Matter (part 2) - Living Things (Animals, plants, seeds, sperm) - Treatment of